195 related articles for article (PubMed ID: 37696912)
21. Detection of
Périchon B; Lichtl-Häfele J; Bergsten E; Delage V; Trieu-Cuot P; Sansonetti P; Sobhani I; Dramsi S
Front Cell Infect Microbiol; 2022; 12():794391. PubMed ID: 35360109
[TBL] [Abstract][Full Text] [Related]
22. Increased Intracellular Cyclic di-AMP Levels Sensitize Streptococcus gallolyticus subsp. gallolyticus to Osmotic Stress and Reduce Biofilm Formation and Adherence on Intestinal Cells.
Teh WK; Dramsi S; Tolker-Nielsen T; Yang L; Givskov M
J Bacteriol; 2019 Mar; 201(6):. PubMed ID: 30617242
[TBL] [Abstract][Full Text] [Related]
23. Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer.
Butt J; Fernández de Larrea N; Tjalsma H; Roelofs R; Kato I; Martín V; Pérez-Gómez B; Moreno V; Dierssen-Sotos T; Castilla J; Fernández-Tardón G; Amiano P; Salas D; Alguacil J; Jiménez-Moleón JJ; Huerta JM; de Sanjosé S; Del Campo R; Kogevinas M; Pollán M; Pawlita M; Waterboer T; Boleij A; Aragonés N
Sci Rep; 2019 Jul; 9(1):10847. PubMed ID: 31350458
[TBL] [Abstract][Full Text] [Related]
24. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
25. Neonatal calf meningitis associated with Streptococcus gallolyticus subsp. gallolyticus.
Aydın F; Güneş V; Çakır Bayram L; Abay S; Karakaya E; Varol K; Ekinci G; Gümüşsoy KS; Müştak HK; Diker KS
Folia Microbiol (Praha); 2019 Mar; 64(2):223-229. PubMed ID: 30232728
[TBL] [Abstract][Full Text] [Related]
26. Relationship among
Romay E; Pericàs JM; García-País MJ; Hernández-Meneses M; Ayuso B; García-González J; Garcés-Durán RV; Rabuñal R; Alonso-García P; García-Garrote F; Perissinotti A; Vidal B; Falces C; Quintana E; Moreira L; Almela M; Llach J; Moreno A; Corredoira J; Miró JM; On Behalf Of Lucus Augusti And Hospital Clinic Endocarditis Teams
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456274
[TBL] [Abstract][Full Text] [Related]
27.
Taddese R; Roelofs R; Draper D; Wu X; Wu S; Swinkels DW; Tjalsma H; Boleij A
Front Cell Infect Microbiol; 2021; 11():740704. PubMed ID: 34778104
[TBL] [Abstract][Full Text] [Related]
28. Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8
Li P; Zhou D; Chen D; Cheng Y; Chen Y; Lin Z; Zhang X; Huang Z; Cai J; Huang W; Lin Y; Ke H; Long J; Zou Y; Ye S; Lan P
J Biomed Sci; 2023 Jun; 30(1):47. PubMed ID: 37380972
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
[TBL] [Abstract][Full Text] [Related]
30. Cotargeting BET proteins overcomes resistance arising from PI3K/mTOR blockade-induced protumorigenic senescence in colorectal cancer.
Lee HS; Lee S; Cho KH
Int J Cancer; 2020 Nov; 147(10):2824-2837. PubMed ID: 32599680
[TBL] [Abstract][Full Text] [Related]
31. Novel Tn916-like elements confer aminoglycoside/macrolide co-resistance in clinical isolates of Streptococcus gallolyticus ssp. gallolyticus.
Kambarev S; Pecorari F; Corvec S
J Antimicrob Chemother; 2018 May; 73(5):1201-1205. PubMed ID: 29438479
[TBL] [Abstract][Full Text] [Related]
32. Detection of Streptococcus gallolyticus in colorectal cancer and inflammatory bowel disease patients compared to control group in southwest of Iran.
Sheikh AF; Masjedi Zadeh AR; Saki M; Khani P; Hashemi SJ; Shahin Zadeh S; Dastoorpoor M
Mol Biol Rep; 2020 Nov; 47(11):8361-8365. PubMed ID: 33128683
[TBL] [Abstract][Full Text] [Related]
33. Identification of Streptococcus gallolyticus subsp. gallolyticus (Biotype I) Competence-Stimulating Peptide Pheromone.
Harrington A; Tal-Gan Y
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29440256
[No Abstract] [Full Text] [Related]
34. Selective Eradication of Colon Cancer Cells Harboring PI3K and/or MAPK Pathway Mutations in 3D Culture by Combined PI3K/AKT/mTOR Pathway and MEK Inhibition.
Atanasova VS; Riedl A; Strobl M; Flandorfer J; Unterleuthner D; Weindorfer C; Neuhold P; Stang S; Hengstschläger M; Bergmann M; Dolznig H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675180
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.
Xu G; Zhang W; Bertram P; Zheng XF; McLeod H
Int J Oncol; 2004 Apr; 24(4):893-900. PubMed ID: 15010827
[TBL] [Abstract][Full Text] [Related]
36. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?
Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601
[TBL] [Abstract][Full Text] [Related]
37. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study.
Corredoira-Sánchez J; García-Garrote F; Rabuñal R; López-Roses L; García-País MJ; Castro E; González-Soler R; Coira A; Pita J; López-Álvarez MJ; Alonso MP; Varela J
Clin Infect Dis; 2012 Aug; 55(4):491-6. PubMed ID: 22563018
[TBL] [Abstract][Full Text] [Related]
38. FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.
Cipriano R; Miskimen KL; Bryson BL; Foy CR; Bartel CA; Jackson MW
Oncotarget; 2013 May; 4(5):729-38. PubMed ID: 23676467
[TBL] [Abstract][Full Text] [Related]
39. Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
Beekhof R; Bertotti A; Böttger F; Vurchio V; Cottino F; Zanella ER; Migliardi G; Viviani M; Grassi E; Lupo B; Henneman AA; Knol JC; Pham TV; de Goeij-de Haas R; Piersma SR; Labots M; Verheul HMW; Trusolino L; Jimenez CR
Sci Transl Med; 2023 Aug; 15(709):eabm3687. PubMed ID: 37585503
[TBL] [Abstract][Full Text] [Related]
40. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
